In summary, the neuroprotective effects of GLP-1RAs have been demonstrated in various in vivo models of diabetes, aging, AD, and PD
Haimerl P, Bernhardt U, Schindela S, Henkel FDR, Lechner A, Zissler UM, et al
PMID: 16352683 Khorram O, Laughlin GA, Yen SS
FDA Approves Lillys Foundayo (orforglipron), the Only GLP-1 Pill for Weight Loss That Can Be Taken Any Time of Day Without Food or Water Restrictions
( Semantic Scholar ) Translation: its not fake. Its also not miracle. Its promising, plausible, and very marketable which is exactly why it will trend